Table 1.
MTBP mRNA is overexpressed in many human cancers
Cancer Type | Fold Change | p-value | Reference |
---|---|---|---|
Breast ductal carcinoma (N=78, C=639) |
1.87 – 2.66 | 1.3E-02 to 3E-23 | (40–42) |
Cervical carcinoma (N=8, C=20) |
2.12 | 1.8E-06 | (43) |
Colorectal carcinoma (N=97, C=273) |
1.60 – 3.71 | 4.6E-04 to 1.2E-19 | (44, 45) |
Gastric adenocarcinoma (N=50, C=91) |
1.43 – 2.25 | 3.1E-04 to 1.9E-10 | (46) |
Glioblastoma (N=23, C=81) |
2.25 | 4.8E-04 | (47) |
Lung adenocarcinoma (N=65, C=45) |
1.54 | 2E-07 | (48) |
Lung large cellcarcinoma (N=65, C=19) |
2.28 | 1.9E-06 | (48) |
Lung squamous cell carcinoma (N=65, C=27) |
1.62 | 1.9E-08 | (48) |
Prostate carcinoma (N=8, C=13) |
1.65 | 9.1E-04 | (49) |
Squamous cell carcinoma (N=4, C=11) |
1.97 | 9.5E-04 | (50) |
MTBP mRNA expression data in cancer (C) compared to normal (N) tissue from Oncomine; p-values determined by log-rank test